IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIACOMINI, Arianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.110
EU - Europa 1.742
AS - Asia 518
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 5
AF - Africa 3
Totale 5.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.104
PL - Polonia 715
CN - Cina 313
UA - Ucraina 297
IT - Italia 250
DE - Germania 179
HK - Hong Kong 116
FI - Finlandia 92
IE - Irlanda 64
GB - Regno Unito 61
VN - Vietnam 36
SE - Svezia 21
IN - India 19
RU - Federazione Russa 16
BE - Belgio 14
TR - Turchia 14
FR - Francia 13
CA - Canada 6
ES - Italia 6
EU - Europa 6
AU - Australia 5
NL - Olanda 4
SG - Singapore 4
PH - Filippine 3
BD - Bangladesh 2
CH - Svizzera 2
GR - Grecia 2
JP - Giappone 2
LK - Sri Lanka 2
MA - Marocco 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 5.389
Salva come PNG Salva come JPEG
Città #
Warsaw 715
Fairfield 542
Woodbridge 334
Ashburn 282
Jacksonville 221
Cambridge 214
Houston 212
Seattle 184
Wilmington 183
Chandler 170
Ann Arbor 144
Brescia 136
Hong Kong 116
Princeton 116
Dearborn 76
Beijing 73
Helsinki 68
New York 64
Dublin 60
Nanjing 51
Dong Ket 35
Des Moines 31
Nanchang 25
San Diego 23
Shenyang 21
Jinan 18
Shanghai 16
Hebei 14
Brussels 13
Milan 12
Changsha 11
London 11
Jiaxing 10
Kocaeli 10
Tianjin 10
Phoenix 9
San Francisco 9
Verona 8
Guangzhou 7
Haikou 7
Lanzhou 7
Hefei 6
Kunming 6
Ningbo 6
Turin 6
Boardman 5
Lancaster 5
Los Angeles 5
Lumezzane 5
Pavia 5
Toronto 5
Washington 5
Gunzenhausen 4
Hangzhou 4
Kilburn 4
Lonate Ceppino 4
Redwood City 4
Taizhou 4
Angeles City 3
Changchun 3
Fuzhou 3
Ivry-sur-seine 3
Norwalk 3
Nürnberg 3
San Mateo 3
Sydney 3
Acton 2
Amsterdam 2
Augusta 2
Barcelona 2
Canberra 2
Catania 2
Chiswick 2
Colombo 2
Falkenstein 2
Islington 2
Lappeenranta 2
Lima 2
Marcheno 2
Modena 2
New Bedfont 2
Orange 2
Padova 2
Ponsacco 2
Rabat 2
Rome 2
Terni 2
Tokyo 2
Zhengzhou 2
Zurich 2
Alzano Lombardo 1
Ardabil 1
Auburn Hills 1
Bergamo 1
Bishkek 1
Bologna 1
Camerino 1
Capannelle 1
Carpinone 1
Chennai 1
Totale 4.433
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 274
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 263
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 220
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 211
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 209
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 195
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 150
Long pentraxin-3 follows and modulates bladder cancer progression 149
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 136
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 133
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 126
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 120
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 120
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 114
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 113
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 108
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 107
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 107
Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature 106
Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth 104
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib 102
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 101
Long pentraxin 3: A novel multifaceted player in cancer 99
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 96
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 93
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 91
Future applications of FGF/FGFR inhibitors in cancer 90
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 89
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 84
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 83
Circulating microRNAs and Their Role in Multiple Myeloma 82
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 81
Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL) 80
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 79
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 77
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 70
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 68
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model 66
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies 59
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 59
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 50
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 50
The FGF/FGFR System in the Physiopathology of the Prostate Gland 49
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 48
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 47
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 46
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 41
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress 38
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 37
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 36
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells 33
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature 32
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 32
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients 30
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 30
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 29
Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma 29
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas 26
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 26
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 25
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft 23
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression 22
Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias 20
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination 12
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 11
FGF-trapping hampers cancer stem-like cells in uveal melanoma 7
Proteasome inhibitors as anticancer agents 6
Totale 5.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019246 0 0 0 0 0 0 0 0 0 0 132 114
2019/20201.710 132 65 79 160 124 214 212 190 142 220 83 89
2020/20211.152 47 104 41 120 64 127 56 134 104 161 102 92
2021/2022593 38 79 29 21 20 40 38 42 16 74 46 150
2022/2023497 80 15 29 29 43 120 6 51 68 1 37 18
2023/2024498 42 13 96 27 20 101 22 26 125 24 2 0
Totale 5.549